Geode Capital Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.72M | Buy |
2,188,275
+165,363
| +8% | +$716K | ﹤0.01% | 2593 |
|
|
2025
Q4 | $7.2M | Sell |
2,022,912
-4,415
| -0.2% | -$27K | ﹤0.01% | 2569 |
|
|
2025
Q3 | $18M | Buy |
2,027,327
+7,532
| +0.4% | +$76.4K | ﹤0.01% | 2047 |
|
|
2025
Q2 | $18.6M | Buy |
2,019,795
+54,985
| +3% | +$469K | ﹤0.01% | 1999 |
|
|
2025
Q1 | $16.9M | Buy |
1,964,810
+89,888
| +5% | +$849K | ﹤0.01% | 1985 |
|
|
2024
Q4 | $20.1M | Sell |
1,874,922
-8,277
| -0.4% | -$63.7K | ﹤0.01% | 1969 |
|
|
2024
Q3 | $10.7M | Buy |
1,883,199
+51,946
| +3% | +$300K | ﹤0.01% | 2339 |
|
|
2024
Q2 | $7.73M | Buy |
1,831,253
+118,526
| +7% | +$479K | ﹤0.01% | 2482 |
|
|
2024
Q1 | $8.72M | Buy |
1,712,727
+47,363
| +3% | +$267K | ﹤0.01% | 2401 |
|
|
2023
Q4 | $15.5M | Buy |
1,665,364
+92,396
| +6% | +$636K | ﹤0.01% | 2064 |
|
|
2023
Q3 | $10.3M | Buy |
1,572,968
+30,668
| +2% | +$244K | ﹤0.01% | 2249 |
|
|
2023
Q2 | $12.5M | Buy |
1,542,300
+89,422
| +6% | +$766K | ﹤0.01% | 2150 |
|
|
2023
Q1 | $12.5M | Buy |
1,452,878
+47,414
| +3% | +$473K | ﹤0.01% | 2117 |
|
|
2022
Q4 | $13M | Buy |
1,405,464
+79,536
| +6% | +$850K | ﹤0.01% | 2076 |
|
|
2022
Q3 | $13.7M | Buy |
1,325,928
+13,706
| +1% | +$145K | ﹤0.01% | 2016 |
|
|
2022
Q2 | $13.1M | Buy |
1,312,222
+4,385
| +0.3% | +$41.5K | ﹤0.01% | 2062 |
|
|
2022
Q1 | $16.1M | Buy |
1,307,837
+10,466
| +0.8% | +$129K | ﹤0.01% | 2029 |
|
|
2021
Q4 | $22.5M | Buy |
1,297,371
+99,262
| +8% | +$1.89M | ﹤0.01% | 1871 |
|
|
2021
Q3 | $21.5M | Buy |
1,198,109
+40,537
| +4% | +$807K | ﹤0.01% | 1911 |
|
|
2021
Q2 | $26.5M | Buy |
1,157,572
+121,887
| +12% | +$1.81M | ﹤0.01% | 1783 |
|
|
2021
Q1 | $15.5M | Buy |
1,035,685
+242,093
| +31% | +$2.64M | ﹤0.01% | 2040 |
|
|
2020
Q4 | $4.29M | Buy |
793,592
+42,775
| +6% | +$225K | ﹤0.01% | 2681 |
|
|
2020
Q3 | $3.42M | Buy |
750,817
+30,092
| +4% | +$130K | ﹤0.01% | 2602 |
|
|
2020
Q2 | $3.54M | Buy |
720,725
+3,144
| +0.4% | +$11.9K | ﹤0.01% | 2520 |
|
|
2020
Q1 | $2.26M | Buy |
717,581
+104,462
| +17% | +$364K | ﹤0.01% | 2607 |
|
|
2019
Q4 | $1.59M | Buy |
613,119
+24,271
| +4% | +$63.7K | ﹤0.01% | 3105 |
|
|
2019
Q3 | $1.86M | Buy |
588,848
+37,085
| +7% | +$107K | ﹤0.01% | 2976 |
|
|
2019
Q2 | $1.86M | Buy |
551,763
+222,915
| +68% | +$692K | ﹤0.01% | 2997 |
|
|
2019
Q1 | $1M | Buy |
328,848
+36,900
| +13% | +$88.1K | ﹤0.01% | 3162 |
|
|
2018
Q4 | $455K | Buy |
291,948
+3,687
| +1% | +$8.37K | ﹤0.01% | 3408 |
|
|
2018
Q3 | $786K | Buy |
288,261
+7,156
| +3% | +$20.2K | ﹤0.01% | 3315 |
|
|
2018
Q2 | $736K | Sell |
281,105
-44,482
| -14% | -$124K | ﹤0.01% | 3302 |
|
|
2018
Q1 | $898K | Buy |
325,587
+7,068
| +2% | +$20K | ﹤0.01% | 3169 |
|
|
2017
Q4 | $1.02M | Buy |
318,519
+7,740
| +2% | +$30.5K | ﹤0.01% | 3088 |
|
|
2017
Q3 | $1.29M | Buy |
310,779
+11,297
| +4% | +$50.2K | ﹤0.01% | 3004 |
|
|
2017
Q2 | $1.59M | Buy |
299,482
+22,508
| +8% | +$130K | ﹤0.01% | 2865 |
|
|
2017
Q1 | $1.59M | Buy |
276,974
+39,934
| +17% | +$206K | ﹤0.01% | 2783 |
|
|
2016
Q4 | $938K | Buy |
237,040
+7,075
| +3% | +$25.2K | ﹤0.01% | 3024 |
|
|
2016
Q3 | $834K | Buy |
229,965
+3,677
| +2% | +$15.5K | ﹤0.01% | 3034 |
|
|
2016
Q2 | $1.38M | Buy |
226,288
+46,739
| +26% | +$226K | ﹤0.01% | 2722 |
|
|
2016
Q1 | $879 | Buy |
179,549
+57,572
| +47% | +$253K | ﹤0.01% | 2950 |
|
|
2015
Q4 | $679K | Buy |
+121,977
| New | +$868K | ﹤0.01% | 3110 |
|
Other funds holding AVXL
VCM
SF
VPM
